Publication | Open Access
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis
80
Citations
30
References
2017
Year
Our data indicate that vedolizumab could be an option in the treatment of patients with chronic, antibiotic-dependent or refractory pouchitis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1